SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
FLUOROPHARMA MEDICAL INC
(NQBB:FPMI Last Sale: .6 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQBB: (FPMI : $.6)
$15 million Market Cap at September 12, 2013
Medical Products SubIndustry up .00% / Health Industry up .00% Today
Montcliar, NJ Research Report Earnings Snapshot - Last 05/15/16
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


engages in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD). Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, amyloid plaque in Alzheimer’s disease and agents for detection of certain types of cancer.
Historical Charts    Technical Analysis
No Historical Data available for FPMI

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common FPMI $.6 $ 0 $.54 $.6 36,000 $.51 $1.19 24,360
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $14,616

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex